These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 3012373)
1. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro. Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373 [TBL] [Abstract][Full Text] [Related]
2. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas. Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254 [TBL] [Abstract][Full Text] [Related]
3. Effects of proglumide on pancreatic acinar cell function. Williams JA; Bailey A; Steigerwalt RW Digestion; 1983; 27(4):227-33. PubMed ID: 6197332 [TBL] [Abstract][Full Text] [Related]
4. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Verspohl EJ; Ammon HP; Williams JA; Goldfine ID Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856 [TBL] [Abstract][Full Text] [Related]
5. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep. Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447 [TBL] [Abstract][Full Text] [Related]
6. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice. Karlsson S; Ahrén B Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765 [TBL] [Abstract][Full Text] [Related]
7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Digestion; 1989; 42(2):61-9. PubMed ID: 2475379 [TBL] [Abstract][Full Text] [Related]
8. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues. Niederau C; Niederau M; Williams JA; Grendell JH Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321 [TBL] [Abstract][Full Text] [Related]
9. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini]. Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851 [TBL] [Abstract][Full Text] [Related]
11. Structural features of various proglumide-related cholecystokinin receptor antagonists. Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats]. Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850 [TBL] [Abstract][Full Text] [Related]
13. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823 [TBL] [Abstract][Full Text] [Related]
14. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini. Iwamoto Y; Yamamoto R; Kuzuya T Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574 [TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion. Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290 [TBL] [Abstract][Full Text] [Related]
16. Treatment with cholecystokinin receptor antagonist loxiglumide enhances insulin response to intravenous glucose stimulation in postpancreatitic rats. Otsuki M; Nakano S; Tachibana I Regul Pept; 1994 Jul; 52(2):85-95. PubMed ID: 7972939 [TBL] [Abstract][Full Text] [Related]
17. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. Hahne WF; Jensen RT; Lemp GF; Gardner JD Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817 [TBL] [Abstract][Full Text] [Related]
18. Effect of proglumide on rat pancreatic growth. Yamaguchi T; Tabata K; Johnson LR Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide. Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192 [TBL] [Abstract][Full Text] [Related]
20. Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans. Funakoshi A; Nakano I; Shinozaki H; Miyazaki K; Ibayashi H Regul Pept; 1987 Jun; 17(6):311-8. PubMed ID: 3299507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]